Download presentation
Presentation is loading. Please wait.
Published by剿取 韶 Modified over 6 years ago
1
Fibulin-3 fragments are prognostic biomarkers of osteoarthritis incidence in overweight and obese women J. Runhaar, C. Sanchez, S. Taralla, Y. Henrotin, S.M.A. Bierma-Zeinstra Osteoarthritis and Cartilage Volume 24, Issue 4, Pages (April 2016) DOI: /j.joca Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions
2
Fig. 1 Competitive inhibition of Poly with the fibulin 3 peptides Fib3-3 and Fib3-2, complete fibulin-3, and BSA. B/B0 is the ratio of coated antigen bound in the presence of free antigen to coated antigen bound in the absence of free antigen. Osteoarthritis and Cartilage , DOI: ( /j.joca ) Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions
3
Fig. 2 Odds ratio's and 95% confidence intervals for all three fibulin-3 epitopes and the selected outcome measures. Osteoarthritis and Cartilage , DOI: ( /j.joca ) Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions
4
Fig. 3 Mean of log- and Z-transformed baseline concentrations for subjects with and without incidence of ACR-criteria (upper row) and chronic pain at follow-up (lower row) for fib3-1 (panels A and D), fib3-2 (panels B and E) and fib3-3 (panels C and F). Statistical significance between incidence or no incidence with Mann–Whitney test. Osteoarthritis and Cartilage , DOI: ( /j.joca ) Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions
5
Fig. 4 Mean baseline and 30 months follow-up concentrations with 95% confidence intervals of fib3-1 (in nM, panels A and D), fib3-2 (in nM, panels B and E) and fib3-3 (in nM, panels C and F) for subjects with and without incidence of ACR-criteria (upper row) and chronic pain at follow-up (lower row). Asterisks mark statistical significance for untransformed baseline concentrations between incidence or no incidence with Mann–Whitney test (P < 0.05). Osteoarthritis and Cartilage , DOI: ( /j.joca ) Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.